Provided by Tiger Trade Technology Pte. Ltd.

COSMOS HEALTH INC

0.2071
-0.0144-6.50%
Volume:1.52M
Turnover:328.72K
Market Cap:20.92M
PE:-0.34
High:0.2280
Open:0.2270
Low:0.2050
Close:0.2215
52wk High:1.32
52wk Low:0.1616
Shares:101.00M
Float Shares:78.78M
Volume Ratio:0.66
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6172
EPS(LYR):-0.6321
ROE:-104.00%
ROA:-18.42%
PB:1.01
PE(LYR):-0.33

Loading ...

Cosmos Health projects FY2029 revenue of $200.6 million, adjusted EBITDA $44.2 million

Reuters
·
Jun 10

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

GlobeNewswire
·
Jun 10

Cosmos Health unit wins contract manufacturing agreement with Provident Pharma

TIPRANKS
·
Jun 10

Cosmos Health unit Cana signs 5-year Provident deal to make 385,000 CERTORUN units

Reuters
·
Jun 10

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line With New 5-Year Contract Manufacturing Agreement With Provident Pharmaceuticals for 385,000 Units of Certorun

THOMSON REUTERS
·
Jun 10

Cosmos Health unit acquires international patent application WO2025108566A1 from Cloudpharm

Reuters
·
Jun 08

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

THOMSON REUTERS
·
Jun 08

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

GlobeNewswire
·
Jun 05

Cosmos Health secures EU-wide distribution for Sky Premium Life via Skroutz

Reuters
·
Jun 05

Cosmos Health - Identifies $20 Mln in Non-Core Assets for Potential Monetization

THOMSON REUTERS
·
Jun 04

Cosmos Health explores monetizing about $20 million in non-core assets to fund acquisitions or cut debt

Reuters
·
Jun 04

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

GlobeNewswire
·
Jun 04

Cosmos Health says it sees no business reason for recent share price decline

Reuters
·
Jun 02

Cosmos Health Provides Balance Sheet Update: Highlights European Investment Bank Financing Discussions for up to €25M, Eliminates 38% of Warrant Overhang With No Dilution; Reaffirms Growth Trajectory; Notes No Known Business Reason for Recent Share Price Decline

THOMSON REUTERS
·
Jun 02

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

GlobeNewswire
·
Jun 01

BRIEF-Cosmos Health Targets $200 Mln Revenue, $44 Mln Adjusted EBITDA By 2029

Reuters
·
May 26

Cosmos Health forecasts 2029 revenue of $200.6 million

Reuters
·
May 26

Cosmos Health- Projects 2029 Stockholders' Equity of $92.3 Mln & per-Share Value Creation With $0.73 EPS

THOMSON REUTERS
·
May 26

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted Ebitda by 2029 — Building an Innovative, High-Margin Healthcare Platform With Strong Cash Generation

THOMSON REUTERS
·
May 26

Cosmos Health Inc - Expects Profitability in 2027, Net Income $31 Mln by 2029

THOMSON REUTERS
·
May 26